Statins may improve your cholesterol but not your cardiac risks

A paper published in this issue of the Annals of Internal Medicine, reviewed the association of statin therapy and cardiovascular outcomes, but found little difference between treated and untreated patients. As the current focus of statin therapy is to reduce low-density lipoprotein cholesterol (LDL-C), rather than increase high-density lipoprotein cholesterol (HDL-C), the conclusion was that persistent low levels of HDL-C may be responsible for ongoing risks of cardiovascular events such as myocardial infarction (MI) and cardiac death.

The ARBITER 6 trial that compared Niacin with Ezitimibe came to the same conclusion in 2009.

Perhaps however, this strengthens another point I made at the time in a previous blog: An atheromatous plaque, once present, will take a lifetime to resolve if such a thing is indeed possible (I think of this as too little, too late). Rather, I believe it is more likely that progression of atherosclerotic disease can be slowed or even stopped with judicious use of Optimal Medical Therapy (OMT). Improving HDL may well play an important role in accelerating this process. What these studies do not take into account are the side effects (flushing, itching and stomach upsets) that frequently  accompany the high dosages required.

Let me know what you think,

Dr T

• Dick Cheney and modern heart failure treatment
• Stenting for stable coronary artery disease is wrong!
• Medical therapy often superior than stenting
• Not so fast! Left-main PCI is only appropriate for minority
• Weight gains after dieting
• PCI vs. CABG in Left Main CAD
• Many patients with coronary artery disease are not treated optimally
• The ABCS of Preventing Heart Attacks and Strokes
• Diastolic Dysfunction and Risk of Heart Failure
• Statin usage in low-risk patients
• TAVI
• Surgery for heart failure
• Cardiac Surgery Risk Analysis
• SYNTAX and CABG
• HDL and CV Risk
• VT-111 results
• Improper Cardiac Stent Implantations
• Small Coronaries
• HbA1c
• SYNTAX 3
• PCI for STEMI should be limited to infarct-related coronary arteries
• Treatment of Chronic Kidney Disease
• Patients with 3-vessel disease should be operated!
• Patients with 3-vessel disease should undergo PCI!
• CT angiography for CAD
• COURAGE under fire
• SYNTAX analysis
• BARI-2D
• OAT Trial
• For Profit Research
• Niacin vs. Ezitimibe
• Stroke & Bypass surgery
• Elective cardiac catherization
• OMTvsPCI stable CAD
• APEX-AMI trial Analysis
• CAS vs CEA (the CREST study)
• Low Diagnostic Yield of Elective Coronary Angiography
• Statins may improve your cholesterol but not your cardiac risks
• Treatment of 3VD with/without Diabetes in Washington State
• An approach to Hypertension Treatment In The Elderly